-
Sector Analysis
Acute Myeloid Leukemia Cell Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2031
Acute Myeloid Leukemia Market Report Overview The AML market value for the 15 markets (15M) was $3.1 billion in 2021. Moreover, the high transplant relapse rate and steady increase in incidence provide a steady flow of cell therapy-eligible patients and will drive market growth during the forecast period. Buy Full Report to Know More About the Acute Myeloid Leukemia Market Forecast Download a Free Report Sample The acute myeloid leukemia market research report offers a comprehensive insight into the market...
-
Thematic Analysis
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update
Since the first case of COVID-19 was diagnosed in Wuhan, China, in December 2019, COVID-19 cases rose rapidly across the globe. On March 11, 2020, World Health Organization (WHO) officially declared that COVID-19 is a pandemic. Over 1,200 clinical trials worldwide have either been disrupted by COVID-19 due to suspended enrollment or delayed initiation or have been impacted by slow enrollment. Regulatory guidance has been issued for industry, investigators, and institutional review boards on conducting clinical trials during the COVID-19...
-
Sector Analysis
Niemann-Pick Type C Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
The Niemann-Pick Type C (NPC) market size was $128.35 million in 2021 and is forecast to achieve a CAGR of more than 3% during the forecast period. Major symptoms of the disease are neurological and developmental disorders, as well as hepatosplenomegaly, jaundice, cholestasis, bleeding disorders, and eventually dysphagia and even respiratory failure in adults. Early diagnosis remains a critically unmet need, with many patients receiving a diagnosis late after the onset of neurological disease and other musculoskeletal disabilities.
-
Thematic Analysis
Electronic Health Records – Analyzing Trends, Technologies, Use Barriers, and Future Prospects
Electronic Health Records (EHRs) have long been touted as a key element for achieving more efficient healthcare. One of the primary aims of EHRs was to improve data flow within healthcare systems, to enhance day-to-day operations and patient care. With EHRs becoming more integrated and technologically advanced, and an increasing number of governments supporting their nationwide implementation, EHR uptake has grown significantly. Nevertheless, several issues, including a lack of standardization, interoperability, data safety, and user acceptance, have emerged as obstacles for their...
-
Sector Analysis
Alport Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
The Alport syndrome pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products, late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR), and Likelihood of Approval (LoA) for Alport syndrome. Â The report also analyzes the clinical and commercial landscapes of Alport syndrome, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment. Alport syndrome (AS) is a genetically and phenotypically heterogeneous, progressive hereditary renal disease that is...
-
Sector Analysis
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule. RCC is the most common type of kidney cancer in adults. While it is considered one of the most lethal urological cancers, the causes of RCC are largely unknown. The most important known etiological risk factors, all of which are modifiable, are tobacco use, high blood pressure, and obesity. The renal cell carcinoma marketed and pipeline drugs market report provides...
-
Sector Analysis
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Cigarette smoking increases the risk of various respiratory and cardiac diseases and is the biggest contributor to the tobacco epidemic, a serious public health threat that kills more than 8 million people a year around the world. Nicotine dependence is recognized as a medical condition in the Diagnostic and Statistical Manual (DSM) of the American Psychiatric Association, and tobacco dependence is recognized in the International Classification of Diseases (ICD). Smoking cessation is defined as the continued dependence on nicotine following...
-
Sector Analysis
Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Alpha-1 Antitrypsin Deficiency Market Report Overview The Alpha-1 Antitrypsin Deficiency (AATD) market size in the 2MM (US and Germany) was valued at $1.36 billion in 2021 and is forecast to grow at a CAGR of more than 12% during the forecast period, 2021-2031. The introduction of 4 new pipeline agents are key drivers of this market growth. AATD is an inherited disease that causes an increased risk of chronic obstructive pulmonary disorder (COPD), hepatic failure, skin problems (panniculitis), and inflammation...
-
Sector Analysis
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Food Allergy Market Overview The food allergy market was valued at $213.9 million in 2020 globally and is forecast to grow at a CAGR of more than 28% during the forecast period. Food Allergy Market Overview, 2020-2030 ($Million) For more insights into the food allergy market forecast, download a free report sample The food allergy market lacks a curative agent, with the only available treatments being antihistamines or epinephrine usage for accidental exposure. The food allergy pipeline consists of 31...
-
Sector Analysis
Sarcoidosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
The sarcoidosis marketed and pipeline drugs assessment reports provides a data-driven overview of the current and future competitive landscape in sarcoidosis therapeutics. Sarcoidosis usually presents with persistent dry cough, eye and skin manifestations, weight loss, fatigue, night sweats, and erythema nodosum. Various factors including infection, genetic predisposition, and environmental factors are involved in the pathology of sarcoidosis. Exposures to insecticides, herbicides, bioaerosols, and agricultural employment are associated with an increased risk for sarcoidosis. An early and accurate diagnosis of sarcoidosis...